Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Polman

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosisMarco Rovaris, Elda Judica, Jaume Sastre-Garriga, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2012
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosisLukas Filli, Louis Hofstetter, Pascal Kuster, et al.
Nature Reviews. Neurology|July 8, 2015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic processÀlex Rovira, Mike P Wattjes, Mar Tintoré, et al.
The Journal of International Medical Research|January 31, 2008
Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosisRachel Farrell, Klaus Bendtzen, Antonio Bertolotto, et al.
Journal of Neurology|April 26, 2007
Neutralising antibodies to interferon beta in multiple sclerosis : expert panel reportHans-P Hartung, Chris Polman, Antonio Bertolotto, et al.
Nature Reviews. Neurology|September 16, 2015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patientsMike P Wattjes, Àlex Rovira, David Miller, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|December 9, 2014
Quantifying progression of multiple sclerosis via classification of depth videosPeter Kontschieder, Jonas F Dorn, Cecily Morrison, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2010
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre studyMarco Rovaris, Maria A Rocca, Frederik Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 28, 2013
Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosisLouis Hofstetter, Yvonne Naegelin, Lukas Filli, et al.
American Journal of Human Genetics|February 18, 2010
Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 geneEveliina Jakkula, Virpi Leppä, Anna-Maija Sulonen, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosisMarco Rovaris, Elda Judica, Jaume Sastre-Garriga, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2012
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosisLukas Filli, Louis Hofstetter, Pascal Kuster, et al.
Nature Reviews. Neurology|July 8, 2015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic processÀlex Rovira, Mike P Wattjes, Mar Tintoré, et al.
The Journal of International Medical Research|January 31, 2008
Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosisRachel Farrell, Klaus Bendtzen, Antonio Bertolotto, et al.
Journal of Neurology|April 26, 2007
Neutralising antibodies to interferon beta in multiple sclerosis : expert panel reportHans-P Hartung, Chris Polman, Antonio Bertolotto, et al.
Nature Reviews. Neurology|September 16, 2015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patientsMike P Wattjes, Àlex Rovira, David Miller, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|December 9, 2014
Quantifying progression of multiple sclerosis via classification of depth videosPeter Kontschieder, Jonas F Dorn, Cecily Morrison, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2010
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre studyMarco Rovaris, Maria A Rocca, Frederik Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 28, 2013
Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosisLouis Hofstetter, Yvonne Naegelin, Lukas Filli, et al.
American Journal of Human Genetics|February 18, 2010
Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 geneEveliina Jakkula, Virpi Leppä, Anna-Maija Sulonen, et al.
Pageof 5